AZNCF - AstraZeneca PLC (AZN) CEO Pascal Soriot on Q4 2021 Results - Earning Call Transcript
AstraZeneca PLC (AZN) Q4 2021 Earning Conference Call February 10, 2022 6:45 AM ET Company Participants Chris Sheldon - Head of Investor Relations Pascal Soriot - CEO & Executive Director Aradhana Sarin - CFO & Executive Director David Fredrickson - Executive Vice-President of Oncology Business Unit Susan Galbraith - EVP of Oncology Research & Development Ruud Dobber - Executive Vice-President of BioPharmaceuticals Business Unit Menelas Pangalos - EVP of BioPharmaceuticals R&D Marc Dunoyer - CEO of Alexion Leon Wang - Executive VP of International & China President Conference Call Participants Timothy Anderson - Wolfe Research Simon Baker - Redburn Sachin Jain - BofA Securities James Gordon - JPMorgan Mark Purcell - Morgan Stanley Stephen Scala - Cowen and Company Richard Parkes - BNP Paribas Exane Emmanuel Papadakis - Deutsche Bank Keyur Parekh - Goldman Sachs Jo Walton - Credit Suisse Michael Leuchten - UBS Luisa Hector - Berenberg Peter Welford
For further details see:
AstraZeneca PLC (AZN) CEO Pascal Soriot on Q4 2021 Results - Earning Call Transcript